Day: March 12, 2025

Figure 1NANO Nuclear Energy Inc. Appoints Dr. Andrew Steer as Head of Regulatory Engagement.New York, N.Y., March 12, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced the addition of Andrew Steer, Ph.D., a recognized specialist in nuclear safety case development as its Head of Regulatory Engagement. Dr. Andrew Steer is a nuclear safety case and regulatory engagement expert with over 18 years of experience in the nuclear industry. Until recently, Dr. Steer served as Head of Licensing and Regulation at MoltexFLEX, a British nuclear energy company developing advanced small modular molten salt reactors. Dr. Steer led the strategy, scope and development of the...

MONROE TOWNSHIP, N.J., March 12, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it received a binding letter of intent to deploy a PowerBuoy® for an undisclosed customer to demonstrate the survivability and suitability of the system for certain multidomain defense and security applications in extreme sea conditions. This follows the signing of a teaming agreement with a major international defense contractor last year to provide its Merrows™ suite of solutions with a focus on certain geographic regions. Mr. Philipp Stratmann, CEO and President of Ocean Power Technologies, expressed enthusiasm about the deployment, stating, “We are excited to advance...

Integration of UDS into SAIC ecosystem accelerates delivery of industry-leading software capabilities and expands offerings for defense customers RESTON, Va., March 12, 2025 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) and Defense Unicorns announced a strategic partnership to increase the delivery of secure, scalable and mission-critical software capabilities for the Department of Defense (DoD). Through this collaboration, SAIC will integrate Defense Unicorns’ Unicorn Delivery Service (UDS) into its existing, robust software delivery ecosystem, streamlining how SAIC deploys and maintains applications across cloud, on-premises and tactical edge environments – ultimately improving operational readiness for today’s warfighters. The DoD relies on software to support mission-critical operations across all...

HCWC expanding revenue streams while strengthening infrastructure and customer engagement  HOLLYWOOD, FL, March 12, 2025 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company operating 19 natural and organic grocery stores across six states, provides a shareholder update highlighting its key growth drivers for 2025, which include operational efficiencies, new revenue streams, investment in key leadership roles and enhanced customer engagement. Healthy Choice Wellness Chairman and CEO Jeff Holman commented, “We are making strategic investments that position HCWC for sustainable growth. By fortifying our team, expanding revenue generation, and enhancing customer engagement, we continue to build a solid foundation for profitability. These initiatives not only drive financial growth...

Biotricity’s latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care. REDWOOD CITY, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, is proud to announce the expansion of its intellectual property (IP) portfolio with 14 new patents. This brings the company’s total to 15 issued patents, with an additional 14 patents pending. The expansion of the company’s IP portfolio underscores Biotricity’s commitment to advancing and improving the patient journey. By streamlining diagnostic processes, Biotricity helps...

MINNEAPOLIS, MN, March 12, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company or FOXO”), provides an update on Myrtle Recovery Centers, Inc., (“Myrtle”) and its behavioral health facility in Oneida, Tennessee, and confirms participation in a major alcohol and drug addiction conference in East Tennessee. Myrtle is pleased to announce that its Oneida, Tennessee substance abuse treatment facility has reached stabilization by maintaining an occupancy rate of 75% or greater since the beginning of 2025. In addition, on occasion, the facility has been at capacity unable to accept additional patients over the same period. Myrtle has also, since the beginning of 2025, finalized a number of in-network contracts with major managed care organizations. Myrtle is also pleased to announce its participation as a...

VANCOUVER, British Columbia, March 12, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce its plans for a $6.5 million exploration program in 2025 (the “Program”) across its portfolio of uranium properties in the Athabasca Basin region in northern Saskatchewan. The Program includes the recently announced follow-up drill program on the Hatchet Lake Uranium Property (“Hatchet”) as well as planned exploration on the Murphy Lake South, GR, Blackwing, Wolverine, and CLK properties. Following an initial evaluation of the exploration potential of the 10 properties under option from Denison Mines Corp. (“Denison”)(TSX: DML, NYSE: DNN), Foremost identified several exploration priorities for 2025. The extensive Program will include drilling, geophysical surveys,...

Oral presentations will highlight the implementation of a validated research-use plasma pTau217 assay in the participant screening process for the Phase 2 ALTITUDE-AD study of sabirnetug NEWTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced upcoming scientific presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in Vienna, Austria from April 1-5, 2025, and the American Academy of Neurology (AAN) Annual Meeting in San Diego, Calif., from April 5-9, 2025. Oral presentations will focus on implementation of a validated research-use plasma...